Xiaoli Zhu
机构：Soochow University, Yancheng Third People's Hospital, Shandong Police College, Guangdong Police College, First Affiliated Hospital of Soochow University, Guangzhou Medical University Cancer Hospital, Guangzhou Medical University · ORCID：0000-0003-0998-0124
发表论文 68 篇 · 总被引 895 次 · h-index 15
代表论文
- Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study (2024 · EClinicalMedicine · 被引 156)
- Transarterial chemoembolization combined with molecularly targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a retrospective cohort study (2023 · Frontiers in Immunology · 被引 19)
- Identifying the factors affecting financial toxicity status in patients with middle and advanced colorectal cancer: a cross-sectional study (2024 · Frontiers in Public Health · 被引 14)
- Prognosis Prediction of CRAFITY Score in HCC Undergoing TACE Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapy (2023 · Journal of Hepatocellular Carcinoma · 被引 13)
- Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆ (2024 · JHEP Reports · 被引 11)
- Immune Indicator Changes in Hepatocellular Carcinoma Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs: A Prognostic Biomarker Analysis (2024 · Journal of Hepatocellular Carcinoma · 被引 8)